Roberta Izzo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
mTOR sustains inflammatory response in celiac disease.
Journal: Scientific reports
Published: August 01, 2019
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.
Journal: Inflammatory bowel diseases
Published: September 11, 2017
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.
Journal: Cell death & disease
Published: November 21, 2016
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.
Journal: Immunology
Published: September 14, 2016
Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis.
Journal: Expert review of clinical immunology
Published: August 06, 2016
Tofacitinib for the treatment of ulcerative colitis.
Journal: Expert opinion on investigational drugs
Published: May 14, 2016
Therapy implications for the role of IL-21 in lupus.
Journal: Expert review of clinical immunology
Published: February 09, 2016
Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.
Journal: Journal of Crohn's & colitis
Published: July 01, 2015
TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice.
Journal: PloS one
Published: December 31, 2014
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut.
Journal: European journal of immunology
Published: October 01, 2014
IL-21 as a therapeutic target in inflammatory disorders.
Journal: Expert opinion on therapeutic targets
Published: August 28, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026